Fertility & Gender-Affirming Testosterone
Ovarian Effects, Fertility Preservation, the Incomplete Contraceptive Effect, and Pregnancy-While-on-T
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Off-label; fertility counseling recommended by WPATH SOC-8 and Endocrine Society
Reference only. Not medical advice.
This is something to take to a clinician. The Atlas can tell you what is known about fertility & gender-affirming testosterone in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Testosterone suppresses the HPG axis, halting ovulation and inducing amenorrhea, and alters ovarian histology, but its long-term effect on fertility is incompletely understood and frequently reversible. Importantly, testosterone is NOT a contraceptive: ovulation can occur despite amenorrhea, and unintended pregnancies on testosterone are documented (Light et al., Obstetrics & Gynecology 2014, surveyed 41 transgender men who experienced pregnancy after transitioning; some conceived while still amenorrheic). Studies of trans men undergoing oocyte retrieval after stopping testosterone report oocyte yields and quality broadly comparable to cisgender women, supporting fertility-preservation feasibility. Both WPATH SOC-8 and the Endocrine Society recommend counseling on fertility impact and preservation options (oocyte/embryo cryopreservation) BEFORE initiating testosterone.
Testosterone stops periods but is NOT birth control, and fertility is often recoverable. Counsel before starting.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
Exogenous testosterone suppresses GnRH-driven LH/FSH secretion, halting cyclic follicular recruitment and ovulation and producing amenorrhea. Ovarian histologic changes (including features sometimes resembling polycystic morphology) are described but do not equate to permanent loss of fertility; resumption of ovulation after discontinuation is common.
Amenorrhea is not infertility, and not contraception
The single most important clinical message is that absence of periods on testosterone does not mean a person cannot conceive. Ovulation can break through suppression, and pregnancies on testosterone are documented. Conversely, the suppression is usually reversible, so testosterone use does not foreclose future biological parenthood for most people, which is exactly why fertility-preservation counseling belongs before initiation, not after.
Safety in detail
This intervention requires medical oversight. Because testosterone is teratogenic and not contraceptive, patients who could become pregnant and wish to avoid it need effective contraception. Fertility-preservation counseling should precede initiation.
What it does to fertility
Testosterone suppresses ovulation and menses, alters ovarian histology, and is teratogenic in pregnancy, but it is not a contraceptive and its effect on fertility is frequently reversible. Fertility-preservation counseling (oocyte or embryo cryopreservation, performed after a period off testosterone) is recommended before initiation.
What people get wrong
Often saidTestosterone is reliable birth control
ActuallyFalse and potentially harmful. Testosterone is not contraceptive; pregnancies occur on it, including in amenorrheic individuals. Separate contraception is needed if pregnancy is to be avoided, and testosterone is teratogenic so effective contraception matters.
Often saidStarting testosterone makes you permanently infertile
ActuallyUsually untrue. Most evidence shows fertility is often recoverable after stopping, with oocyte yields after retrieval comparable to cisgender women. Long-term certainty is limited, which is why preservation is discussed in advance.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
What we do not know
- What is the cumulative effect of many years of testosterone on ovarian reserve?
- How does duration of testosterone exposure affect later fertility-treatment success?
- What proportion of people resume spontaneous ovulation, and how quickly, after stopping?
At a glance
- Effect
- Suppresses ovulation; induces amenorrhea; alters ovarian histology
- Contraception
- NOT reliable, pregnancy can occur on testosterone
- Reversibility
- Often recoverable; many resume ovulation after stopping
- Preservation
- Oocyte/embryo cryopreservation; counsel before starting
- Key survey
- Light et al. 2014-41 trans men pregnant after transitioning
- Oocyte retrieval
- Yields/quality broadly comparable to cis women after T cessation
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Fertility & Gender-Affirming Testosterone. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- What can go wrong. We have not written the risk line for this one. Read the safety section below rather than treating its absence as reassurance.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Transgender men who experienced pregnancy after female-to-male gender transitioning (Light, Obedin-Maliver, Sevelius, Kerns; Obstetrics & Gynecology)2014
Web survey of 41 trans men who became pregnant after transitioning; a subset conceived while amenorrheic and/or had used testosterone, underscoring that T is not contraceptive
Fertility-preservation and oocyte-retrieval outcomes in trans men (multiple cohorts)2019-2023
After stopping testosterone, oocyte yield and quality and embryo outcomes are broadly comparable to cisgender women, supporting feasibility of preservation